+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Post Marketing Surveillance"

Pharmaceutical Services Outsourcing Market - Global Forecast 2025-2032 - Product Thumbnail Image

Pharmaceutical Services Outsourcing Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 194 Pages
  • Global
From
Pharmaceutical Analytical Testing Market Report 2025 - Product Thumbnail Image

Pharmaceutical Analytical Testing Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Pharmaceutical Cro Market Report: Size, Share, Growth Drivers, Trends, Opportunities & Forecast 2025-2030 - Product Thumbnail Image

Pharmaceutical Cro Market Report: Size, Share, Growth Drivers, Trends, Opportunities & Forecast 2025-2030

  • Report
  • October 2025
  • 83 Pages
  • Global
From
U.S. Regulatory Affairs Market Size, Share & Trends Analysis Report by Type (in-house, Outsourced), by Service, by Product, by Indication, by Product Stage, by Company Size, by End Use, and Segment Forecasts, 2025-2033 - Product Thumbnail Image

U.S. Regulatory Affairs Market Size, Share & Trends Analysis Report by Type (in-house, Outsourced), by Service, by Product, by Indication, by Product Stage, by Company Size, by End Use, and Segment Forecasts, 2025-2033

  • Report
  • August 2025
  • 120 Pages
  • United States
From
UAE Biotechnology and Pharmaceutical Services Outsourcing Market, By Region, Competition, Forecast and Opportunities, 2020-2030F - Product Thumbnail Image

UAE Biotechnology and Pharmaceutical Services Outsourcing Market, By Region, Competition, Forecast and Opportunities, 2020-2030F

  • Report
  • January 2025
  • 82 Pages
  • United Arab Emirates United Arab Emirates
From
GAMP® Data Integrity 21 CFR Part 11, 2-Day Training Course (Recorded) - Product Thumbnail Image

GAMP® Data Integrity 21 CFR Part 11, 2-Day Training Course (Recorded)

  • Training
  • December 2024
  • 2 Days
  • Global
From
Risk-Based Approach to CSV, 21 CFR Part 11 and FDA Compliance (Recorded) - Product Thumbnail Image

Risk-Based Approach to CSV, 21 CFR Part 11 and FDA Compliance (Recorded)

  • Training
  • June 2024
  • 90 Minutes
  • Global
Data Integrity by Design and Pharma 4.0: Next-Gen Techniques to Approach GxP Systems, and FDA Compliance (Recorded) - Product Thumbnail Image

Data Integrity by Design and Pharma 4.0: Next-Gen Techniques to Approach GxP Systems, and FDA Compliance (Recorded)

  • Training
  • December 2023
  • 2 Days
  • Global
From
Pharma 4.0: A Different Way to Approach GxP Products, Systems, and Compliance with FDA (Recorded) - Product Thumbnail Image

Pharma 4.0: A Different Way to Approach GxP Products, Systems, and Compliance with FDA (Recorded)

  • Training
  • April 2023
  • 2 Days
  • Global
From
FDA Modernization and Restructuring of the SDLC for Computer System Validation (CSV) and Compliance - Product Thumbnail Image

FDA Modernization and Restructuring of the SDLC for Computer System Validation (CSV) and Compliance

  • Training
  • 90 Minutes
  • Global
Computer System Validation (CSV) vs. Computer System Assurance (CSA): Aligning the Agile Methodology to the GAMP®5 "V" Model and System Development Life Cycle (SDLC) Methodology - Product Thumbnail Image

Computer System Validation (CSV) vs. Computer System Assurance (CSA): Aligning the Agile Methodology to the GAMP®5 "V" Model and System Development Life Cycle (SDLC) Methodology

  • Training
  • 120 Minutes
  • Global
How to Comply with FDA Regulations for Tobacco-Related Products: Computer System Validation, 21 CFR Part 11, & Data Integrity - Product Thumbnail Image

How to Comply with FDA Regulations for Tobacco-Related Products: Computer System Validation, 21 CFR Part 11, & Data Integrity

  • Training
  • 90 Minutes
  • Global
Good Documentation Practice (GDP) and FDA Validation Compliance for Regulated Computer Systems and Data - Product Thumbnail Image

Good Documentation Practice (GDP) and FDA Validation Compliance for Regulated Computer Systems and Data

  • Training
  • 90 Minutes
  • Global
FDA Compliance and Clinical Trial Computer System Validation - Product Thumbnail Image

FDA Compliance and Clinical Trial Computer System Validation

  • Training
  • 60 Minutes
  • Global
Data Integrity Compliance for Computer Systems Regulated by FDA - Product Thumbnail Image

Data Integrity Compliance for Computer Systems Regulated by FDA

  • Training
  • 90 Minutes
  • Global
21 CFR Part 11, FDA's Guidance for Electronic Records and Electronic Signatures - Product Thumbnail Image

21 CFR Part 11, FDA's Guidance for Electronic Records and Electronic Signatures

  • Training
  • 90 Minutes
  • Global
Best Practices in Preparation for an FDA Computer System Audit - Product Thumbnail Image

Best Practices in Preparation for an FDA Computer System Audit

  • Training
  • 90 Minutes
  • Global
FDA Compliance and Enforcement Trends focused on Data Integrity - Product Thumbnail Image

FDA Compliance and Enforcement Trends focused on Data Integrity

  • Training
  • 90 Minutes
  • Global
Medical Device Cybersecurity and FDA Compliance - Webinar - Product Thumbnail Image

Medical Device Cybersecurity and FDA Compliance - Webinar

  • Webinar
  • 90 Minutes
  • Global
From
  • 19 Results (Page 1 of 1)
Loading Indicator

Post Marketing Surveillance (PMS) is a process used in the pharmaceutical manufacturing industry to monitor the safety and efficacy of drugs after they have been approved and released to the public. It involves collecting data from clinical trials, patient reports, and other sources to assess the safety and effectiveness of a drug. PMS also helps to identify any potential side effects or adverse reactions that may occur after a drug has been released. This data is then used to inform regulatory decisions and to ensure that the drug is safe and effective for its intended use. PMS is an important part of the pharmaceutical manufacturing process, as it helps to ensure that drugs are safe and effective for their intended use. It also helps to identify any potential risks associated with a drug, allowing manufacturers to take corrective action if necessary. Some companies in the PMS market include GlaxoSmithKline, Pfizer, Merck, Novartis, and Sanofi. Show Less Read more